» Articles » PMID: 19388864

The Efficacy and Tolerability of Adjunctive Alternative Herbal Medicine (Salvia Miltiorrhiza and Pueraria Lobata) on Vascular Function and Structure in Coronary Patients

Overview
Date 2009 Apr 25
PMID 19388864
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Danshen and gegen (D&G) have long been used in treatment of angina and other cardiac symptoms in Chinese materia medica. Recent pharmacological studies suggest their therapeutic values. We aimed to evaluate the efficacy and safety of Salvia miltiorrhiza (danshen) and Pueraria lobata (gegen) in secondary prevention.

Methods: One hundred (100) consecutive coronary patients (mean age 58 +/- 8 years) were randomized to adjunctive treatment with D&G combination (3 g) or placebo (6 capsules) for 24 weeks in double-blind parallel fashion, followed by optional open-label D&G (1.5 g/day) for 6 more months. Brachial flow-mediated dilation (FMD) and carotid intima-media thickness (IMT) were measured using ultrasound.

Results: Baseline characteristics were similar between the 2 groups. After 24 weeks and compared with baseline, there were no significant changes in blood pressures, blood hematological and biochemical profiles, or folate and homocysteine levels in both groups, but there was a mild decrease in low density lipoprotein (LDL) cholesterol in both groups (p < 0.05). Brachial FMD improved during D&G (p < 0.001) and less so during placebo treatment (p < 0.05), while improvement in carotid IMT was observed only in the D&G group (p < 0.05). After open-label D&G treatment for 6 more months (n = 45), further improvement in both brachial FMD (p < 0.0001) and carotid IMT (p < 0.0001) was observed. Eight (8) adverse events were reported-6 during placebo and 2 during D&G treatment-requiring treatment termination in 2 patients (on placebo).

Conclusions: D&G adjunctive treatment in coronary patients was well tolerated and effective in improving vascular function and structure. These two herbs may become a novel agent for secondary prevention.

Citing Articles

Exploring the Therapeutic Potential of and Genera in Cancer, Diabetes, and Cardiovascular Diseases: A Short Review of Clinical Evidence.

Tavares W, Seca A, Barreto M J Clin Med. 2025; 14(3).

PMID: 39941696 PMC: 11818717. DOI: 10.3390/jcm14031028.


Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials.

Xie L, Liu J, Wang X, Liu B, Li J, Li J Front Cardiovasc Med. 2024; 11:1407536.

PMID: 39055660 PMC: 11269158. DOI: 10.3389/fcvm.2024.1407536.


The effective constituent puerarin, from , inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p/IGF1 pathway.

Li J, Li Y, Yuan X, Yao D, Gao Z, Niu Z Pharm Biol. 2022; 61(1):1-11.

PMID: 36537316 PMC: 9788726. DOI: 10.1080/13880209.2022.2099430.


Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials.

Liang B, Gu N Front Cardiovasc Med. 2021; 8:702110.

PMID: 34422929 PMC: 8377193. DOI: 10.3389/fcvm.2021.702110.


Safety of high-dose in adolescent rats based on metabolomics.

Chen L, Jiang E, Guan Y, Xu P, Shen Q, Liu Z Food Sci Nutr. 2021; 9(2):794-810.

PMID: 33598164 PMC: 7866568. DOI: 10.1002/fsn3.2044.